Lopez-Guillermo, A, Canales, MA, Dlouhy, I, Mercadal, S, Briones, J, Garcia-Sancho, AM, Sancho, JM, Moraleda, JM, Terol, MJ, Salar, A, Palomera, L, Gardella, S, Jarque, I, Ferrer, S, Bargay, J, Lopez, A, Panizo, C, Muntanola, A, Montalban, C, Conde, E, Hernandez, MT, Soler, A, Marco, JAG, Deben, G, Marin, J, Tomas, JF. A randomized phase II study comparing consolidation with a single dose of Y-90 ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results. LEUKEMIA & LYMPHOMA. 2022; 63(1)DOI:10.1080/10428194.2021.1971216. PMID:34459702. IF:2.600(Q3/7D).

Pinana, JL, Lopez-Corral, L, Martino, R, Montoro, J, Vazquez, L, Perez, A, Martin-Martin, G, Facal-Malvar, A, Ferrer, E, Pascual, MJ, Sanz-Linares, G, Gago, B, Sanchez-Salinas, A, Villalon, L, Conesa-Garcia, V, Olave, MT, Lopez-Jimenez, J, Marcos-Corrales, S, Garcia-Blazquez, M, Garcia-Gutierrez, V, Hernandez-Rivas, JA, Saus, A, Espigado, I, Alonso, C, Hernani, R, Solano, C, Ferrer-Lores, B, Guerreiro, M, Ruiz-Garcia, M, Munoz-Bellido, JL, Navarro, D, Cedillo, A, Sureda, A. SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group. AMERICAN JOURNAL OF HEMATOLOGY. 2022; 97(1)DOI:10.1002/ajh.26385. PMID:34695229. IF:12.800(Q1/1D).

Kanda, J, Hayashi, H, Ruggeri, A, Kimura, F, Volt, F, Takahashi, S, Kako, S, Tozatto-Maio, K, Yanada, M, Sanz, G, Uchida, N, Angelucci, E, Kato, S, Mohty, M, Forcade, E, Tanaka, M, Sierra, J, Ohta, T, Saccardi, R, Fukuda, T, Ichinohe, T, Kimura, T, Rocha, V, Okamoto, S, Nagler, A, Atsuta, Y, Gluckman, E. The impact of GVHD on outcomes after adult single cord blood transplantation in European and Japanese populations. BONE MARROW TRANSPLANTATION. 2022; 57(1)DOI:10.1038/s41409-021-01479-4. PMID:34635798. IF:4.800(Q1/2D).

Rucker, FG, Du, L, Luck, TJ, Benner, A, Krzykalla, J, Gathmann, I, Voso, MT, Amadori, S, Prior, TW, Brandwein, JM, Appelbaum, FR, Medeiros, BC, Tallman, MS, Savoie, L, Sierra, J, Pallaud, C, Sanz, MA, Jansen, JH, Niederwieser, D, Fischer, T, Ehninger, G, Heuser, M, Ganser, A, Bullinger, L, Larson, RA, Bloomfield, CD, Stone, RM, Dohner, H, Thiede, C, Dohner, K. Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results. LEUKEMIA. 2022; 36(1)DOI:10.1038/s41375-021-01323-0. PMID:34316017. IF:11.400(Q1/1D).

Pallares, V, Unzueta, U, Falgas, A, Avino, A, Nunez, Y, Garcia-Leon, A, Sanchez-Garcia, L, Serna, N, Gallardo, A, Alba-Castellon, L, Alamo, P, Sierra, J, Cedo, L, Eritja, R, Villaverde, A, Vazquez, E, Casanova, I, Mangues, R. A multivalent Ara-C-prodrug nanoconjugate achieves selective ablation of leukemic cells in an acute myeloid leukemia mouse model. BIOMATERIALS. 2022; 280DOI:10.1016/j.biomaterials.2021.121258. PMID:34847435. IF:14.000(Q1/1D).

Moreno, C, Mora, A. MRD in CLL: some answers, many questions. BLOOD. 2021; 138(26)DOI:10.1182/blood.2021013435. PMID:34967869. IF:25.669(Q1/1D).

Jimenez, AMJ, De Lima, M, Komanduri, KV, Wang, TP, Zhang, MJ, Chen, KR, Abdel-Azim, H, Abid, MB, Aljurf, M, Alkhateeb, H, Assal, A, Bacher, U, Baron, F, Battiwalla, M, Beitinjaneh, A, Bejanyan, N, Bhatt, VR, Byrne, M, Cahn, JY, Cairo, M, Castillo, P, Copelan, E, DeFilipp, Z, Perez, MAD, Elsawy, M, Gale, RP, George, B, Grunwald, MR, Hildebrandt, GC, Hogan, WJ, Kanakry, CG, Kansagra, A, Kharfan-Dabaja, MA, Khera, N, Krem, MM, Lazaryan, A, Maakaron, J, Martino, R, McGuirk, J, Michelis, FV, Milone, G, Mishra, A, Murthy, HS, Mussetti, A, Nathan, S, Nishihori, T, Olsson, RF, Palmisiano, N, Patel, S, Saad, A, Seo, S, Sharma, A, Solh, M, Verdonck, LF, Wirk, B, Yared, JA, Litzow, M, Kebriaei, P, Hourigan, CS, Saber, W, Weisdorf, D. An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis. BONE MARROW TRANSPLANTATION. 2021; 56(12)DOI:10.1038/s41409-021-01450-3. PMID:34584240. IF:5.174(Q2/3D).

Granell, M, Senin, A, Barata, A, Cibeira, MT, Gironella, M, Lopez-Pardo, J, Motllo, C, Garcia-Guinon, A, Ben-Azaiz, R, Abella, E, Soler, A, Canet, M, Marti, JM, Martino, R, Sierra, J, de Larrea, CF, Oriol, A, Rosinol, L. Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma. BONE MARROW TRANSPLANTATION. 2021; 56(12)DOI:10.1038/s41409-021-01429-0. PMID:34404917. IF:5.174(Q2/3D).

Diefenbach, C, Kahl, BS, McMillan, A, Briones, J, Banerjee, L, Cordoba, R, Miall, F, Burke, JM, Hirata, J, Jiang, YW, Paulson, JN, Chang, YM, Musick, L, Abrisqueta, P. Polatuzumab vedotin plus obinutuzumab and lenalidomide in patients with relapsed or refractory follicular lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study. Lancet Haematology. 2021; 8(12)DOI:10.1016/S2352-3026(21)00311-2. PMID:34826412. IF:30.153(Q1/1D).

Albiol, N, Arguello-Tomas, M, Moreno, C. The road to chemotherapy-free treatment in chronic lymphocytic leukaemia. CURRENT OPINION IN ONCOLOGY. 2021; 33(6)DOI:10.1097/CCO.0000000000000791. PMID:34474439. IF:3.915(Q3/6D).

Moreno, C, Munoz, C, Terol, MJ, Hernandez-Rivas, JA, Villanueva, M. Restoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2021; 40(1)DOI:10.1186/s13046-021-02115-1. PMID:34654437. IF:12.658(Q1/1D).

Einsele, H, Briones, J, Ciceri, F, Cadenas, IG, Falkenburg, F, Bolanos, N, Heemskerk, HMM, Houot, R, Hudecek, M, Locatelli, F, Morgan, K, Morris, EC, O'Dwyer, M, Sierra, JG, van den Brink, M, van de Loosdrecht, AA. The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies. Hemasphere. 2021; 5(10)DOI:10.1097/HS9.0000000000000642. PMID:34522844. IF:8.300(Q1/2D).

Genesca, E, Morgades, M, Gonzalez-Gil, C, Fuster-Tormo, F, Haferlach, C, Meggendorfer, M, Montesinos, P, Barba, P, Gil, C, Coll, R, Moreno, MJ, Martinez-Carballeira, D, Garcia-Cadenas, I, Vives, S, Ribera, J, Gonzalez-Campos, J, Diaz-Beya, M, Mercadal, S, Artola, MT, Cladera, A, Tormo, M, Bermudez, A, Vall-llovera, F, Martinez-Sanchez, P, Amigo, ML, Monsalvo, S, Novo, A, Cervera, M, Garcia-Guinon, A, Ciudad, J, Cervera, J, Hernandez-Rivas, JM, Granada, I, Haferlach, T, Orfao, A, Sole, F, Ribera, JM. Adverse prognostic impact of complex karyotype (>= 3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL). LEUKEMIA RESEARCH. 2021; 109DOI:10.1016/j.leukres.2021.106612. PMID:34139642. IF:3.715(Q3/6D).

Ribera, JM, Morgades, M, Coll, R, Barba, P, Lopez-Lorenzo, JL, Montesinos, P, Foncillas, MA, Cabrero, M, Gomez-Centurion, I, Morales, MD, Varela, MR, Herrera, P, Garcia-Cadenas, I, Calbacho, M, Torrent, A, Maluquer, C, Calabuig, M, Garcia-Guinon, A, Bautista, G, Llorente, L, Gil, C, Artola, MT, Gonzalez-Campos, J, Fernandez-Moreno, A, Barez, A, Gimenez-Perez, T, Bergua, J, Sanchez-Sanchez, MJ, Mateos, MC, Pinana, JL. Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain. Clinical Lymphoma Myeloma & Leukemia. 2021; 21(10)DOI:10.1016/j.clml.2021.06.024. PMID:34376375. IF:2.822(Q3/8D).

Ribera, JM, Morgades, M, Genesca, E, Chapchap, EC, Montesinos, P, Acuna-Cruz, E, Gil, C, Garcia-Cadenas, I, Barba, P, Gonzalez-Campos, J, de Llano, MPQ, Torrent, A, Ribera, J, Granada, I, Bernal, T, Diaz-Beya, M, Amigo, ML, Coll, R, Tormo, M, Vall-llovera, F, Gomez-Centurion, I, Sanchez-Sanchez, MJ, Soria, B, Cladera, A, Artola, MT, Garcia-Guinon, A, Gimenez-Conca, A, Amador, ML, Martinez-Sanchez, P, Algarra, JL, Vidal, MJ, Alonso, N, Maluquer, C, Llorente, L, Garcia-Boyero, R, Ciudad, J, Feliu, E, Orfao, A. Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials. HEMATOLOGICAL ONCOLOGY. 2021; 39(4)DOI:10.1002/hon.2910. PMID:34405901. IF:4.850(Q2/5D).

Ljungman, P, de la Camara, R, Mikulska, M, Tridello, G, Aguado, B, Al Zahrani, M, Apperley, J, Berceanu, A, Bofarull, RM, Calbacho, M, Ciceri, F, Lopez-Corral, L, Crippa, C, Fox, ML, Grassi, A, Jimenez, MJ, Demir, SK, Kwon, M, Llamas, CV, Lorenzo, JLL, Mielke, S, Orchard, K, Porras, RP, Vallisa, D, Xhaard, A, Knelange, NS, Cedillo, A, Kroger, N, Pinana, JL, Styczynski, J. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey. LEUKEMIA. 2021; 35(10)DOI:10.1038/s41375-021-01302-5. PMID:34079042. IF:12.897(Q1/1D).

Esquirol, A, Pascual, MJ, Kwon, M, Perez, A, Parody, R, Ferra, C, Cadenas, IG, Herruzo, B, Dorado, N, Hernani, R, Sanchez-Ortega, I, Torrent, A, Sierra, J, Martino, R. Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide. BONE MARROW TRANSPLANTATION. 2021; 56(10)DOI:10.1038/s41409-021-01328-4. PMID:34059802. IF:5.174(Q2/3D).

Sierra, J, Nomdedeu, JF. CEBPA bZip mutations: just a single shot. BLOOD. 2021; 138(13)DOI:10.1182/blood.2021011263. PMID:34591099. IF:25.669(Q1/1D).

Dohner, H, Malcovati, L, Ossenkoppele, GJ, Hochhaus, A, Vannucchi, AM, Bullinger, L, Cervantes, F, Craddock, C, de Witte, T, Dohner, K, Dombret, H, Fenaux, P, Geissler, J, Germing, U, Guilhot, F, Harrison, C, Hellstrom-Lindberg, E, Passamonti, F, Sierra, J, Skoda, R, Wierzbowska, A. The EHA Research Roadmap: Malignant Myeloid Diseases. Hemasphere. 2021; 5(9)DOI:10.1097/HS9.0000000000000635. PMID:34476345. IF:8.300(Q1/2D).

Larson, RA, Mandrekar, SJ, Huebner, LJ, Sanford, B, Laumann, K, Geyer, S, Bloomfield, CD, Thiede, C, Prior, TW, Dohner, K, Marcucci, G, Voso, MT, Klisovic, RB, Galinsky, I, Wei, AH, Sierra, J, Sanz, MA, Brandwein, JM, de Witte, T, Niederwieser, D, Appelbaum, FR, Medeiros, BC, Tallman, MS, Krauter, J, Schlenk, RF, Ganser, A, Serve, H, Ehninger, G, Amadori, S, Gathmann, I, Dohner, H, Stone, RM. Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial. LEUKEMIA. 2021; 35(9)DOI:10.1038/s41375-021-01179-4. PMID:33654204. IF:12.897(Q1/1D).